PHI with Hepatic veno-occlusive disease
How does this condition affect your private health insurance?
Lebervenenverschlusskrankheit, or hepatic veno-occlusive disease (VOD), now commonly termed sinusoidal obstruction syndrome (SOS), is a severe liver condition characterized by damage to the sinusoidal endothelial cells and small hepatic venules. This leads to their occlusion by cell debris and thrombi, impairing blood flow through the liver. It typically manifests as ascites, hepatomegaly, jaundice, and weight gain, often following high-dose chemotherapy or radiation, particularly before hematopoietic stem cell transplantation. The severity varies widely; mild cases may resolve, but severe forms can rapidly progress to multi-organ failure and be fatal. Early diagnosis and treatment are crucial to improve prognosis.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Typically acute, manifesting within 3 weeks post-exposure, resolving over several weeks in mild cases or progressing rapidly within days in severe cases.
Duration of Illness (Lifetime)
Often a one-time acute event; however, severe cases can lead to chronic liver damage or be fatal.
Cost of Treatment (Initial)
Potentially very high, ranging from thousands to hundreds of thousands of Euros/Dollars, especially for severe cases requiring intensive care, specialized medications like defibrotide, and prolonged hospitalization.
Cost of Treatment (Lifetime)
Mainly concentrated at first occurrence. If chronic liver damage ensues, ongoing management and potential liver transplantation can lead to lifelong, substantial costs.
Mortality Rate
Highly variable; low in mild cases, but can exceed 50-80% in severe, multi-organ failure forms, particularly after allogeneic hematopoietic stem cell transplantation.
Risk of Secondary Damages
High, especially in severe forms. Can include acute kidney injury, pulmonary complications, multi-organ failure, and chronic liver fibrosis/cirrhosis in survivors.
Probability of Full Recovery
Possible in mild cases, often with supportive care. Less likely in severe forms where residual liver damage or other organ complications can persist.
Underlying Disease Risk
Often a complication of high-dose chemotherapy and/or radiation therapy for underlying hematological malignancies (e.g., leukemia, lymphoma) or other conditions requiring hematopoietic stem cell transplantation.